As part of the experimental validation, EGFR detection was benchmarked against a melanoma line lacking EGFR expression (MM074, negative control) and a breast cancer line with high EGFR expression (MDA-MB-231, positive control), confirming the specificity of the detection method (data not shown). This evidence concerns the gene EGFR and breast cancer.